Intriguingly, SMARCA4/2 inhibition affects distinct programs in POU2F3 SCLC cells than those we have observed in SCLC-A and SCLC-N, suggesting a different function for SMARCA4 in high vs low-NE SCLC subtypes. The gene discussed is SMARCA4; the disease is small cell lung carcinoma.